City’s largest share sale in four years shows Beijing’s determination to push China’s EV technologies worldwide, analysts say ...

Trading in the shares is expected to start on May 23. Read more at straitstimes.com. Read more at straitstimes.com.

Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.

SINGAPORE] Companies have been flocking to file applications for initial public offerings (IPOs) in Hong Kong amid ...

Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

This digital payment services provider is likely to get a lift from China's initiatives to boost domestic consumption.

Law firms may want to rethink the pivot from Hong Kong to the U.S., given Trump’s tariffs have made way for a potential thaw ...

(Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a ...

Hong Kong is calling for robotaxi operator Pony AI . The $6 billion Chinese company is exploring an offering in the city just ...

HONG KONG] One of this year’s biggest listings is coming together in Hong Kong without the involvement of Wall Street banks.

Chinese EV battery giant CATL aims to raise $4 billion in its Hong Kong listing scheduled for May 20, said a statement filed ...

Chinese EV battery giant CATL aims to raise US$4 billion in its Hong Kong listing scheduled for May 20, said a statement ...